Onconetix, Inc. — Director's Dealing 2022

May 27, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-05-04

Reporting Person: Henderson Erin (Chief Business Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-04	Stock Option	$6.45	A	200000	Acquired	2032-05-04	Common Stock, par value $0.00001 per share (200000)	Direct

Footnotes

F1: Stock options (the "Options") were granted to Ms. Henderson on May 4, 2022. The Options vest and become exercisable as follows (i) 127,800 Options vested immediately upon grant; (ii) 1,306 Options vest at the end of each calendar month from the date of issuance through December 31, 2023 and (iii) 1,920 Options vest at the end of each calendar month thereafter through December 31, 2025.